Market Introduction
Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.
Market Overview and Dynamics
TheMiddle East & Africakidney disease market is expected to reach US$ 7,406.2 million in 2027 from US$ 4,834.1million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027.The growth of this market is estimated to grow owing to key driving factors such asrising prevalence of diabetes resulting in renal diseases and rising incidences of renal diseases. However, the market is expected experiencing slow growth during the forecast period owing to the constraint of finance and resources in developing countries.
Key Market Segments
Based on product, the kidney disease market is segmented diagnosis and treatment. The diagnosis segment is further sub-segmented into blood tests, urine tests, imaging tests, and others. The treatment segment is further sub-segmented into dialysis, drug class, and others. The drug class is sub-divided into ACE inhibitors, angiotensin-2 receptor blockers, diuretics, and others.Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories,and others.
Major Sources and Companies Listed
Some of the major primary and secondary sources forkidney disease market included in the report areSaudi Center for Organ Transplantation (SCOT), Kidney International Reports, and others.
Reasons to buy the report
MIDDLE EAST & AFRICAKIDNEY DISEASE MARKET SEGMENTATION
· Diagnosis
o Blood Tests
o Urine Tests
o Imaging Tests
o Others
· Treatment
o Dialysis
o Others
o Drug Class
§ ACE Inhibitors
§ Angiotensin-II Receptor Blockers
§ Diuretics
§ Others
· Hospitals
· Diagnostic Laboratories
· Others
By Country
· Middle East & Africa
o UAE
o Saudi Arabia
o South Africa
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 4,834.1 Million |
| Market Size by 2027 | US$ 7,406.2 Million |
| CAGR (2020 - 2027) | 5.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Kidney Disease Market is valued at US$ 4,834.1 Million in 2019, it is projected to reach US$ 7,406.2 Million by 2027.
As per our report Middle East and Africa Kidney Disease Market, the market size is valued at US$ 4,834.1 Million in 2019, projecting it to reach US$ 7,406.2 Million by 2027. This translates to a CAGR of approximately 5.5% during the forecast period.
The Middle East and Africa Kidney Disease Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Kidney Disease Market report:
The Middle East and Africa Kidney Disease Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Kidney Disease Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Kidney Disease Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Kidney Disease Market
